Indian Journal of Critical Care Medicine
Medknow Publications on behalf of the Indian Society of Critical Care Medicine
Vol. 12, No. 3, 2008, pp. 140-144
Bioline Code: cm08029
Full paper language: English
Document type: Special Article
Document available free of charge
Indian Journal of Critical Care Medicine, Vol. 12, No. 3, 2008, pp. 140-144
© Copyright 2008 Indian Journal of Critical Care Medicine.
Artificial blood is a product made to act as a substitute for red blood cells. While true blood serves many different functions, artificial blood is designed for the sole purpose of transporting oxygen and carbon dioxide throughout the body. Depending on the type of artificial blood, it can be produced in different ways using synthetic production, chemical isolation, or recombinant biochemical technology. Development of the first blood substitutes dates back to the early 1600s, and the search for the ideal blood substitute continues. Various manufacturers have products in clinical trials; however, no truly safe and effective artificial blood product is currently marketed. It is anticipated that when an artificial blood product is available, it will have annual sales of over $7.6 billion in the United States alone.
Blood, artificial blood, Perfluorocarbons
Alternative site location: http://www.ijccm.org/